{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:40:57Z","timestamp":1794534057972,"version":"4.9.1"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H04754"],"award-info":[{"award-number":["21H04754"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016986","name":"Nippon Zenyaku Kogyo Kabushiki Kaisha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016986","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016983","name":"Yamaguchi University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016983","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Veterinary Immunology and Immunopathology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.vetimm.2024.110792","type":"journal-article","created":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T12:40:09Z","timestamp":1718282409000},"page":"110792","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Development of an in vitro assay for screening programmed death receptor-1\/programmed cell death ligand 1 monoclonal antibody therapy in dogs"],"prefix":"10.1016","volume":"274","author":[{"given":"Takuya","family":"Mizuno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Tsukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaya","family":"Igase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vetimm.2024.110792_bib1","article-title":"Development of canine PD-1\/PD-L1 specific monoclonal antibodies and amplification of canine T cell function","volume":"15","author":"Choi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.vetimm.2024.110792_bib2","doi-asserted-by":"crossref","DOI":"10.4142\/jvs.23144","article-title":"Proof-of-concept study of the caninized anti-canine programmed death 1 antibody in dogs with advanced non-oral malignant melanoma solid tumors","volume":"25","author":"Igase","year":"2024","journal-title":"J. Vet. Sci."},{"key":"10.1016\/j.vetimm.2024.110792_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/vco.12829","article-title":"Long-term survival of dogs with stage 4 oral malignant melanoma treated with anti-canine PD-1 therapeutic antibody: a follow-up case report","author":"Igase","year":"2022","journal-title":"Vet. Comp. Oncol."},{"key":"10.1016\/j.vetimm.2024.110792_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-75533-4","article-title":"A pilot clinical study of the therapeutic antibody against canine PD-1 for advanced spontaneous cancers in dogs","volume":"10","author":"Igase","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vetimm.2024.110792_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jim.2010.09.020","article-title":"T cell stimulator cells, an efficient and versatile cellular system to assess the role of costimulatory ligands in the activation of human T cells","volume":"362","author":"Leitner","year":"2010","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.vetimm.2024.110792_bib6","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1038\/s41598-017-09444-2","article-title":"A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma","volume":"7","author":"Maekawa","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.vetimm.2024.110792_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246188","article-title":"Development of monoclonal antibodies targeting canine PD-L1 and PD-1 and their clinical relevance in canine apocrine gland anal sac adenocarcinoma","volume":"14","author":"Minoli","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.vetimm.2024.110792_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68470-9","article-title":"Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment","volume":"10","author":"Mizuno","year":"2020","journal-title":"Sci Rep."},{"key":"10.1016\/j.vetimm.2024.110792_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vetimm.2018.02.007","article-title":"Development and characterization of monoclonal antibodies against canine PD-1 and PD-L1","volume":"198","author":"Nemoto","year":"2018","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.vetimm.2024.110792_bib10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3390\/cancers13040785","article-title":"Cross-reactivity and functionality of approved human immune checkpoint blockers in dogs","volume":"13","author":"Pantelyushin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.vetimm.2024.110792_bib11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.molimm.2012.01.002","article-title":"Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targeting","volume":"50","author":"Singer","year":"2012","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.vetimm.2024.110792_bib12","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpba.2017.05.011","article-title":"Development of a robust reporter gene assay to measure the bioactivity of anti-PD-1\/anti-PD-L1 therapeutic antibodies","volume":"145","author":"Wang","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.vetimm.2024.110792_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1144869","article-title":"Reversing stage III oral adenocarcinoma in a dog treated with anti-canine PD-1 therapeutic antibody: a case report","volume":"10","author":"Xu","year":"2023","journal-title":"Front Vet. Sci."},{"key":"10.1016\/j.vetimm.2024.110792_bib14","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2287250","article-title":"Development and pharmacokinetic assessment of a fully canine anti-PD-1 monoclonal antibody for comparative translational research in dogs with spontaneous tumors","volume":"15","author":"Yoshimoto","year":"2023","journal-title":"MAbs"},{"key":"10.1016\/j.vetimm.2024.110792_bib15","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41586-022-05673-2","article-title":"Reducing affinity as a strategy to boost immunomodulatory antibody agonism","volume":"614","author":"Yu","year":"2023","journal-title":"Nature"}],"container-title":["Veterinary Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242724000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165242724000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T18:23:24Z","timestamp":1721931804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165242724000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":15,"alternative-id":["S0165242724000783"],"URL":"https:\/\/doi.org\/10.1016\/j.vetimm.2024.110792","relation":{},"ISSN":["0165-2427"],"issn-type":[{"value":"0165-2427","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an in vitro assay for screening programmed death receptor-1\/programmed cell death ligand 1 monoclonal antibody therapy in dogs","name":"articletitle","label":"Article Title"},{"value":"Veterinary Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vetimm.2024.110792","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110792"}}